| Literature DB >> 36259006 |
Emma M Schnittka1, Nick W Lanpher1, Praful Patel2.
Abstract
Research evaluating optimal repair techniques for the reduction of postpartum dyspareunia following obstetric laceration is severely limited. Prevailing guidelines from the American College of Obstetricians and Gynecologists (ACOG) are reliant on data from just nine clinical trials conducted from 1980 to 2012. While the literature on this topic is still limited today, this review aims to synthesize data from past and present studies to ensure that standing clinical recommendations are supported by current literature. A review was conducted per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Medical Literature Analysis and Retrieval System Online (MEDLINE), Cochrane Library, and Google Scholar were searched. Included articles (1) compared continuous with interrupted repair techniques for subjects with episiotomies and/or second-degree tears, (2) were available in full length, and (3) reported dyspareunia as an outcome variable. Excluded articles were those (1) inclusive of first-, third-, or fourth-degree tears; (2) comparing suture material rather than technique; and (3) not available in English. A meta-analysis was conducted for both acute dyspareunia (<3 months) and chronic dyspareunia (>3 months) utilizing Meta-Essentials Microsoft Excel (Microsoft Corp., Redmond, WA) workbook. Bias was evaluated via Egger regression and Begg and Mazumdar rank correlation tests. Twelve articles met inclusion and exclusion guidelines, seven for acute dyspareunia and eight for chronic dyspareunia. All publications were randomized controlled trials and were inclusive of a total of 4,081 patients. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated using a random effect model. Analysis revealed no statistically significant difference between continuous and interrupted suture groups for acute dyspareunia (RR: 0.98; 95% CI: 0.89-1.08) or chronic dyspareunia (RR: 0.96; 95% CI: 0.83-1.12). Egger regression test (p-value=0.534) and Begg and Mazumdar rank correlation test (p-value=0.570) indicated minimal publication bias. Compiled data does not indicate a preferential suture technique for the reduction of postpartum dyspareunia. These findings are congruent with the ACOG guidelines; therefore, there is no supporting evidence for ACOG's recommendation of continuous suturing to be overturned.Entities:
Keywords: continuous suture; dyspareunia; episiotomy; interrupted suture; perineal tear
Year: 2022 PMID: 36259006 PMCID: PMC9559366 DOI: 10.7759/cureus.29070
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1PRISMA 2020 flow diagram for new systematic reviews, which included searches of databases, registers, and other sources
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
From: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136/bmj.n71. For more information, visit http://www.prisma-statement.org/
Summary of reviewed literature
CG: continuous suture group; IG: interrupted suture group; VAS: visual analog scale
| Country of origin | Included in Kettle et al.'s 2012 analysis | Conclusion(s) | Notes | |
| Almeida (2008) [ | Brazil | Yes | No significant difference in dyspareunia; CG with reduced perineal pain four days postpartum | Dyspareunia data collected from CG at 49 days +/- 15.7 days and IG at 45.8 d +/-15.1, approximated at seven weeks postpartum |
| Morano (2006) [ | Italy | Yes | No significant difference in dyspareunia; CG with reduced acute pain and analgesia use | |
| Valenzuela (2009) [ | Spain | Yes | No significant difference in dyspareunia; CG with reduced suture time and amount of suture material used | |
| Kettle (2002) [ | The United Kingdom | Yes | No significant difference in dyspareunia; CG with reduced perineal pain at 10 days postpartum | |
| Perveen (2009) [ | Pakistan | Yes | No significant difference in dyspareunia; IG associated with increased number of suture packets used | |
| Mahomed (1989) [ | England | Yes | CG with higher overall dyspareunia rate; IG subjects had increased need for removal of suture material | Potential bias due to variation in suture material, layers repaired, and injury type (episiotomy, tear, or both); authors note some non-compliance to allocated suture technique by midwives (values not given) |
| Isager-Sally (1986) [ | Denmark | Yes | No significant difference in long-term dyspareunia; CG with reduced acute discomfort, incontinence, and dyspareunia and improved cosmetic results | Authors note that females experiencing dyspareunia were offered pelvic examination, which deduced "25% (of complaints) related directly to the episiotomy scar while in 75%, there were unrelated reasons" |
| Detlefsen (1980) [ | Denmark | Yes | CG experienced reduced acute dyspareunia, with no significant difference in chronic dyspareunia; CG recommended due to reduced edema, subjective discomfort, and need for postpartum analgesia | |
| Croce (1997) [ | Italy | Yes | No significant difference in dyspareunia; improved aesthetic in CG at four days and three months postpartum | |
| Kindberg (2008) [ | Denmark | No | No significant difference in dyspareunia; CG with reduced suture time, amount of suture used, and cost | Low compliance to allocated suture technique by midwives (77% CG and 80% IG); potential bias due to the use of both rapidly absorbable and standard polyglactin 910 |
| Kokanalı (2011) [ | Turkey | No | No significant difference in dyspareunia; CG with reduced suturing time, suture material used, and perineal pain at one day postpartum | Pain rated using VAS scores, value of four or higher considered moderate/severe pain [ |
| Aydın Besen (2020) [ | Turkey | No | No significant difference in dyspareunia; CG with reduced suture time, suture material used, perineal pain, and analgesia used; CG with improved wound healing |
Data summary: admission or denial of acute dyspareunia at listed intervals
CG: continuous suture group; IG: interrupted suture group
*Kindberg (2008) first intercourse timeframe not specified [8]
**Valenzuela (2009) first intercourse: average of 49 days in CG and 45 days in IG [11]
| Suture | CG | IG | Admits, CG | Denies, CG | Admits, IG | Denies, IG | |
| Almeida (2008) [ | Polyglactin 910, rapidly absorbable | 12 | 11 | 7 weeks: 5 | 7 weeks: 7 | 7 weeks: 5 | 7 weeks: 6 |
| Valenzuela (2009) [ | Polyglactin 910, rapidly absorbable | 198 | 186 | First intercourse**: 109 | First intercourse: 89 | First intercourse: 110 | First intercourse: 76 |
| Perveen (2009) [ | Catgut | 50 | 50 | 6 weeks: 3 | 6 weeks: 47 | 6 weeks: 2 | 6 weeks: 48 |
| Perveen (2009) [ | Polyglactin 910, standard | 50 | 50 | 6 weeks: 3 | 6 weeks: 47 | 6 weeks: 3 | 6 weeks: 47 |
| Croce (1997) [ | Catgut | 96 | 99 | 1 month: 32 | 1 month: 64 | 1 month: 27 | 1 month: 72 |
| Detlefsen (1980) [ | Polyglycolic acid | 63 | 50 | 2 months: 48 | 2 months: 15 | 2 months: 45 | 2 months: 5 |
| Kindberg (2008) [ | Polyglactin 910, rapidly absorbable or standard | 198 | 197 | First intercourse*: 124 | First intercourse: 74 | First intercourse: 111 | First intercourse: 86 |
| Kokanalı (2011) [ | Polyglactin 910, rapidly absorbable | 10 | 9 | 6 weeks: 9 | 6 weeks: 1 | 6 weeks: 7 | 6 weeks: 2 |
| Kokanalı (2011) [ | Polyglycolide-co-caprolactone | 9 | 11 | 6 weeks: 8 | 6 weeks: 1 | 6 weeks: 10 | 6 weeks: 1 |
Data summary: admission or denial of chronic dyspareunia at listed intervals
CG: continuous suture group; IG: interrupted suture group
| Suture | CG | IG | Admits, CG | Denies, CG | Admits, IG | Denies, IG | |
| Morano (2006) [ | Polyglactin 910, rapidly absorbable | 87 | 78 | 3 months: 18 | 3 months: 69 | 3 months: 18 | 3 months: 60 |
| Kettle (2002) [ | Polyglactin 910, standard | 298 | 290 | 3 months: 47 | 3 months: 251 | 3 months: 48 | 3 months: 242 |
| Kettle (2002) [ | Polyglactin 910, rapidly absorbable | 283 | 303 | 3 months: 51 | 3 months: 232 | 3 months: 54 | 3 months: 249 |
| Mahomed (1989) [ | Polyglycolic acid, catgut, or silk | 424 | 401 | 3 months: 116 | 3 months: 308 | 3 months: 94 | 3 months: 307 |
| Isager-Sally (1986) [ | Polyglycolic acid | 265 | 250 | 3 months: 45 | 3 months: 220 | 3 months: 58 | 3 months: 192 |
| Detlefsen (1980) [ | Polyglycolic acid | 63 | 50 | 6 months: 28 | 6 months: 35 | 6 months: 19 | 6 months: 31 |
| Croce (1997) [ | Catgut | 96 | 99 | 3 months: 24 | 3 months: 72 | 3 months: 25 | 3 months: 74 |
| Kindberg (2008) [ | Polyglactin 910, rapidly absorbable or standard | 198 | 197 | 6 months: 47 | 6 months: 151 | 6 months: 58 | 6 months: 139 |
| Aydın Besen (2020) [ | Unspecified | 26 | 27 | 3 months: 6 | 3 months: 20 | 3 months: 11 | 3 months: 16 |